Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
2016 ◽
Vol 26
(9)
◽
pp. 1401-1411
◽
2020 ◽
Vol 43
(7)
◽
pp. 983-993
◽
2015 ◽
Vol 194
(1)
◽
pp. 255-261
◽